Asia Pacific ICU ventilators market is expected to register a healthy CAGR in the forecast period 2019 to 2026. The new market report contains data for historic years 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.
Access Full Report at https://databridgemarketresearch.com/reports/global-icu-ventilators-market/
High prevalence of chronic respiratory diseases:
Ventilators are used for the life support treatments for chronic diseases such as hypercapnic respiratory failure, restrictive lung disease, dyspnea on exertion, asthma, orthopnea, chronic obstructive pulmonary disease (COPD), chronic interstitial lung diseases (ILDs), pneumonia, cardiogenic pulmonary edema, neurologic disease and bronchial asthma. There is an increase in the chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, occupational lung diseases and pulmonary hypertension.
There are two types of acute and chronic respiratory failure, hypoxemic and hypercapnic. Hypoxemic respiratory failure includes the deficiency of the oxygen in blood with normal carbon dioxide whereas hypercapnic respiratory failure includes higher carbon dioxide in the blood with normal or less oxygen. These chronic respiratory failures are treated with the mechanical ventilation or breathing machine, which pumps oxygen through the mouth or nose of patients.
TABLE 1 Worldwide statistics related to COPD & Asthma in 2015
|Diseases||People died in 2015||CAGR (1990-2015)|
|Age-standardised prevalence decreased||-||14·7%|
|age-standardised death rate decreased||-||58·8%|
|prevalence of asthma increased||-||12·6%|
|age-standardised prevalence decreased||-||17·7%|
The high prevalence of chronic respiratory diseases is increasing the death rate which ultimately helps in the demand of ICU ventilators in the hospital for critical care patients to save their life. Rising number of chronic diseases and companies initiatives towards the awareness of the COPD, pneumonia and different ventilation systems offered by the various companies like Drägerwerk AG & Co. KGaA (Germany), Medtronic (Ireland) etc will stimulate the growth of the market in the forecast period of 2019 to 2026.
Increasing government expenditures on healthcare
Government plays a vital role in improving the healthcare sector providing some health benefits to individuals with the help of some health insurance program, medicare and other facilities. Government helps in healthcare by increase in per capita of country based on its economy. Due to the increase in the mortality rate in the ICU departments government has increased the healthcare expenditure. As per an article published in Tax policy center, Federal Government has expended around USD 1.1 trillion on health care in the year of 2018.
TABLE 2 Federal spending and Tax expenditure for healthcare in 2018
|Services||Expenditure (fiscal year 2018)|
|Medicare claim||USD 583 billion|
|Medicaid and the Children’s Health Insurance Program (CHIP)||USD 399 billion|
|Veterans’ Medical Care||USD 70 billion|
|Various Tax Provisions For Health Care Reduced Income Tax Revenue||USD 225 billion|
|Exclusion From Taxable Income Of Employers||USD 146 billion|
The cost and use of federal government subsidies for health insurance for people under age 65, the government invested USD 685 billion in 2018 on such subsidies helping 89.0% of the 273 million people under age 65 in the United States get health insurance.
TABLE 3 Composition of Federal spending on Healthcare in the U.S.
|Medicare and Medicaid (65+)||USD 604 billion|
|Medicare and Medicaid (Under 65)||USD 378 billion|
|Tax break for employer provided insurance||USD 272 billion|
|Veterans Medical Care||USD 70 billion|
|ACA Subsidies||USD 55 billion|
|Defence Health Program||USD 51 billion|
Hence, we can observe that the government is increasing healthcare expenditure to save the patient’s life where ventilator has its importance in saving every breath of patient in the hospital.
Increasing number of ICU bed
The demand for ICU beds for critical care patients is increasing day by day and the resources expended on critical care continues to rise. Many initiatives have been taken to increase the use of existing ICU beds by shifting the admission of low-intensity patients and end-of-life care to other departments of the hospital.
The rising number of chronic diseases such as COPD, ventilator associated pneumonia and other disorders can enhance the occupancy ofthe beds of the ICU’s with mechanical ventilation. The paediatric and neonatal ICUs are from major teaching hospitals, and partly from some private sector hospitals.
TABLE 4 ICU Patients admitted in respective departments, U.S.
|Neonatal- preterm birth||70-90%|
|Acute Care Admissions||20%|
|Pediatric ICU based on chronic conditions||53% of children|
TABLE 5 Number of ICU patients by ventilation status, Canada, 2011–2014
(less than 96 hours)
|No ventilation or
Hence it is observed that there is an increase in the demand of ICU beds which ultimately affects the increase in the market value of ventilators for both invasive as well as non-invasive ventilators.
Rising number of geriatric population and pre-term birth
According to the World Health Organization (WHO), geriatric population is the elderly population aged 65 and over, and the preterm birth is a premature birth which happens before the 37th week of pregnancy.
TABLE 6 Pre- term births of few countries in 2018
|United States of America||517,400|
|Democratic Republic of the Congo||341,400|
A rising number of geriatric population and pre-term birth is increasing day by day which leads to an increase in the number of ICU patients which requires invasive ventilator for their survival.
High cost of invasive ventilators
The invasive ventilators are majorly used for critical care patients which are used in the bigger hospitals who can afford this device and able to use it on their patients whenever required. This device is expensive as it is a lifesaving machine which can be used by skilled professional. The small hospitals and clinics cannot purchase this product due to its high cost and maintenance.
As per an article published by WHO, the cost of the Intensive care ventilators is ranging from 9,000 - 60,000 USD where this pricing varies with the customer requirements in the device and its mode.
Hence, the high cost of the ventilators system, less affordability amongst the poor population and less investment of the low economic countries in the ventilation system can hamper the growth of the market in the coming year.
Technological innovation, portability, and design
Many technologically advanced, portable, and design oriented ventilators are available in the market, following are few examples of the technologically advanced products:
Side-effects of Invasive ventilator
A long term application of mechanical ventilation can create a risk to treated patients such as Pneumothorax. Pneumothorax is a condition in which air leaks out from lung into the space between lung and chest, which can lead the lungs to collapse or damage. This can be caused due to the pumping of excess airflow or oxygen from the ventilator. According to the National Center for Biotechnology Information (NCBI), Pneumothorax, bronchopleural fistula, and the development of nosocomial pneumonia are the most common medical complications of invasive ventilators.
The examples of equipment-related complications are a failure of the ventilator to the cycle of proper functioning of safety alarms, and of inspired gas to be properly heated or humidified. The challenge for a professional is when to intubate, what setting the ventilator should be set at and troubleshooting the ventilator.
Ventilator associated pneumonia (VAP) is a lung infection for which patients require treatment in ICUs and in VAP process pneumonia occurs⩾48 hrs after incubation with the start of mechanical ventilation which can cause a high risk of gastric bleeding in the patients with ventilation.
Increasing treatments of the ventilator associated pneumonia (VAP) is the major challenge for the ventilator market for instance, according to the Centers for Disease Control and Prevention (CDC), in 2011, in the U.S. around 157,000 healthcare-associated pneumonias occurred in acute care hospitals in the U.S in which 39.0% of the pneumonia was ventilator associated.
Hence, increasing number of the cases with the chronic diseases such as respiratory issues, ventilator associated pneumonia, lung infections and rising requirement of the mechanical ventilation amongst the population can fuel the growth of the market whereas major risk associated with the mechanical ventilation can hamper the growth of the market.
Some of the prominent players operating in this market are Dragerwerk AG & Co. KGaA(Germany), Koninklijke Philips N.V.(Netherlands), Medtronic(Ireland), Hamilton Medical(Switzerland), Lowenstein Medical(Germany), Heyer Medical AG(Germany), Getinge AB.(Sweden), VYAIRE(U.S.) and many others.
Global ICU Ventilators Market – Industry Trends and Forecast to 2027
Europe ICU Ventilators Market – Industry Trends and Forecast to 2027
Asia-Pacific ICU Ventilators Market – Industry Trends and Forecast to 2027
North America ICU Ventilators Market - Industry Trends and Forecast to 2027
Middle East and Africa ICU Ventilators Market – Industry Trends and Forecast to 2027
Global ICU Ventilators Market is Expected to Grow at 7.6% in the Forecast Period of 2020 to 2027
Europe ICU Ventilators Market is Expected to Register a Healthy CAGR in the Forecast Period of 2019 to 2026
North America ICU Ventilators Market is Expected to Register a Healthy CAGR in the Forecast Period of 2019 to 2026